Association of T-Cell Receptor Repertoire Use With Response to Combined Trastuzumab-Lapatinib Treatment of HER2-Positive Breast Cancer Secondary Analysis of the NeoALTTO Randomized Clinical Trial
Ryan L Powles, David Redmond, Christos Sotiriou, Sherene Loi, Debora Fumagalli, Paolo Nuciforo, Nadia Harbeck, Evandro de Azambuja, Severine Sarp, Serena Di Cosimo, Jens Huober, Jose Baselga, Martine Piccart-Gebhart, Olivier Elemento, Lajos Pusztai, Christos Hatzis
JAMA Oncology | AMER MEDICAL ASSOC | Published : 2018
Awarded by Yale Cancer Center Core Grant
Awarded by NATIONAL CANCER INSTITUTE
This project was supported by Investigator Awards from the Breast Cancer Research Foundation and by a Yale Cancer Center Core Grant (NCI P30 CA16359-34) to Drs Hatzis and Pusztai and by a Susan G. Komen Foundation grant to Dr Pusztai.